Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP-BACK: Erector Spinae Plane Block for Acute Low Back Pain
2024-511595-32-00Phase 4Authorised
- Sponsor
- Centre Hospitalier Universitaire de Montpellier
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute lumbago comparing ESP block with ropivacaine with Placebo / sham ESP block (2 arms). Primary endpoints: Reduction of pain on mobilization at 30 minutes and Get Up and Go test at 30 minutes. Planned start Nov 2025; status: authorised.
02
Drugs
ropivacaine
03
Conditions
acute lumbago
Beyond the preview
Go deeper on 2024-511595-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511595-32-00.